Systemic lupus erythematosus and secondary antiphospholipid syndrome diagnosed after pulmonary thromboembolism in a male patient
Turkiye Klinikleri Cardiovascular Sciences, cilt.29, sa.3, ss.82-85, 2017 (Scopus, TRDizin)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 29 Sayı: 3
- Basım Tarihi: 2017
- Doi Numarası: 10.5336/cardiosci.2017-59238
- Dergi Adı: Turkiye Klinikleri Cardiovascular Sciences
- Derginin Tarandığı İndeksler: Scopus, TR DİZİN (ULAKBİM)
- Sayfa Sayıları: ss.82-85
- Anahtar Kelimeler: Antiphospholipid syndrome, Pulmonary thromboembolism, Systemic lupus erythematosus
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
Systemic lupus erythematosus (SLE) is an autoimmune, chronic, and multisystemic disease that can cause variable clinical manifestations. Antiphospholipid syndrome (APS) is a systemic autoimmune disease which occurs secondary to antiphospholipid antibodies (aPL) and results in vascular thromboses and/or pregnancy morbidity. Both diseases are more common in women. In this article, a male patient diagnosed with SLE and secondary APS during the etiologic investigations in terms of pulmonary thromboembolism will be discussed.